Trial studying safety and effects for Long Covid-19
Official title Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in People With Long COVID-19.
ClinicalTrials.gov ID: NCT06928480
What this study is testing
- What it's testing
- The study will see if the Unified Protocol helps reduce anxiety, depression, and stress in people with long COVID and if the benefits last up to a year.
- Who it's for
- Adults who have long COVID and also have anxiety or depression.
- What's involved
- Participants join an online group that follows the Unified Protocol, attend sessions, and have hair samples taken to measure stress hormones.
- Time commitment
- The program lasts several weeks, with follow‑up visits up to 12 months after the last session.
- Time commitment: about 12 months
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Residing in Autonomous Community of Aragon (Spain).
- Being at least 18 years old.
- Understanding of Spanish.
- Being diagnosed with long COVID-19: documented SARS-CoV-2 infection and persistence of symptoms beyond 12 weeks after the acute infection.
- Symptoms of depression (ODSIS≥7) and/or anxiety (OASIS≥8).
You likely can't join if
- Pre-existing emotional symptoms prior to the acute SARS-CoV-2 infection.
- Actually receiving psychological treatment.
- Having a diagnosis of severe mental disorder (e.g., personality disorder, bipolar disorder, etc.).
- Active suicidal ideation at the time of the assessment.
- Individuals on psychotropic medication must maintain their dosage throughout the study, unless medically contraindicated.
See the full eligibility criteria
- Residing in Autonomous Community of Aragon (Spain).
- Being at least 18 years old.
- Understanding of Spanish.
- Being diagnosed with long COVID-19: documented SARS-CoV-2 infection and persistence of symptoms beyond 12 weeks after the acute infection.
- Symptoms of depression (ODSIS≥7) and/or anxiety (OASIS≥8).
- Meeting the criteria for an emotional disorder diagnosis.
- Having access to Internet.
- Signing the informed consent.
- Pre-existing emotional symptoms prior to the acute SARS-CoV-2 infection.
- Actually receiving psychological treatment.
- Having a diagnosis of severe mental disorder (e.g., personality disorder, bipolar disorder, etc.).
- Active suicidal ideation at the time of the assessment.
- Individuals on psychotropic medication must maintain their dosage throughout the study, unless medically contraindicated.
The study team makes the final eligibility decision.
Where it is enrolling
- Zaragoza, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Zaragoza, Spain. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.